Real World Testing of a Brain-Computer Interface

Sponsor
University of Pittsburgh (Other)
Overall Status
Recruiting
CT.gov ID
NCT04026581
Collaborator
National Institute on Disability, Independent Living, and Rehabilitation Research (U.S. Fed)
20
2
50.9
10
0.2

Study Details

Study Description

Brief Summary

The goal of this project is to test a new AAC-BCI device comparing gel and dry electrode headgear used for communication while providing clinical care. Innovative resources will be employed to support the standard of care without considering limitations based on service billing codes. Clinical services will include AAC assessment, AAC-BCI device and treatment to individuals with minimal movement due to amyotrophic lateral sclerosis (ALS), brain stem strokes, severe cerebral palsy, traumatic brain injury (TBI) and their family support person. This is a descriptive study designed to measure and monitor the communication performance of individuals using the AAC-BCI, any other AAC strategies, their user satisfaction and perceptions of communication effectiveness, and the satisfaction of the family support persons.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Speech generating device (SGD) evaluation including BCI access
  • Behavioral: Training and treatment

Detailed Description

This clinical trial follows a descriptive study design collecting data to measure and monitor variables related to the standard of care in providing speech language pathology augmentative and alternative communication clinical (AAC) assessment and treatment. The study tracks participants through the AAC, speech generating device trial and AAC-BCI trial processes. In addition this study measures and monitors the communication performance of individuals using the AAC-BCI and any other AAC strategies for treatment in the home. Data on communication performance, user satisfaction, and perceptions of communication effectiveness are gathered over monthly visits along with the satisfaction and perceptions of communication effectiveness by the family support persons.

Study Design

Study Type:
Observational
Anticipated Enrollment :
20 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Real World Testing of a Brain-Computer Interface to Operate a Commercial Augmentative and Alternative Communication System
Actual Study Start Date :
Jun 5, 2019
Anticipated Primary Completion Date :
Aug 31, 2022
Anticipated Study Completion Date :
Aug 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Assessment

A comprehensive AAC assessment collecting clinical and personal data required to select a speech-generating device (SGD) is conducted along with a trial of three AAC technology solutions, followed by a trial for BCI access to an AAC system.

Behavioral: Speech generating device (SGD) evaluation including BCI access
At the initial evaluation the participants will review the full range of AAC options and speech generating devices (SGDs) and complete a speech and language evaluation. The second evaluation date will involve a trial of SGDs matched to the participant's assessment results. The third visit is the trial of an AAC system with BCI access. Should the dry electrode headgear for BCI access prove ineffective, then the gel electrode cap will be offered to the participant for trial. At the end of the third visit, the evaluation results will be discussed with participant and family, and they will be asked to select the preferred SGD.

Training and Treatment

AAC training and treatment services will be provided and communication performance outcomes monitored over the course of studying clinical treatment services. At monthly home visits the SLP gathers clinical and personal data on communication performance outcomes and user satisfaction of their AAC system and any alternative access methods.

Behavioral: Training and treatment
Participants receive training on the selected SGD followed by monthly treatment sessions from the SLP who monitors performance. In some cases the participants' SGD will be an AAC system with BCI access. In this case training will also include an identified system support person. Use of the SGD is monitored on a monthly basis through home visits and/or tele-practice sessions, when requested. Technical support for the SGD is provided on an as needed basis or when requested by the participant or support person.

Outcome Measures

Primary Outcome Measures

  1. Change in daily communication performance [Baseline vs. 1 month]

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

  2. Change in daily communication performance [1 month vs. 2 months]

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

  3. Change in daily communication performance [2 months vs. 3 months]

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

  4. Change in daily communication performance [3 months vs. 4 months]

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

  5. Change in daily communication performance [4 months vs. 5 months]

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

  6. Change in daily communication performance [5 months vs. 6 months]

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

  7. Change in daily communication performance [6 months vs. 7 months]

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

  8. Change in daily communication performance [7 months vs. 8 months]

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

  9. Change in daily communication performance [8 months vs. 9 months]

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

  10. Change in daily communication performance [9 months vs. 10 months]

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

  11. Change in daily communication performance [10 months vs. 11 months]

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

  12. Change in daily communication performance [11 months vs. 12 months]

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

  13. Change in daily communication performance [12 months vs. 13 months]

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

  14. Change in daily communication performance [13 months vs. 14 months]

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

  15. Change in daily communication performance [14 months vs. 15 months]

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

  16. Change in daily communication performance [15 months vs. 16 months]

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

  17. Change in daily communication performance [16 months vs. 17 months]

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

  18. Change in daily communication performance [17 months vs. 18 months]

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

  19. Change in daily communication performance [18 months vs. 19 months]

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

  20. Change in daily communication performance [19 months vs. 20 months]

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

  21. Change in daily communication performance [20 months vs. 21 months]

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

  22. Change in daily communication performance [21 months vs. 22 months]

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

  23. Change in daily communication performance [22 months vs. 23 months]

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

  24. Change in daily communication performance [23 months vs. 24 months]

    Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.

Secondary Outcome Measures

  1. User satisfaction of speech generating device (SGD) for daily communication [Baseline vs. 1 month]

    Rating scale of user satisfaction with a range of 0-21 with a lower score representing a better outcome.

  2. User satisfaction of speech generating device (SGD) for daily communication [1 month vs. 2 months]

    Rating scale of user satisfaction with a range of 0-21 with a lower score representing a better outcome.

  3. User satisfaction of speech generating device (SGD) for daily communication [2 months vs. 3 months]

    Rating scale of user satisfaction with a range of 0-21 with a lower score representing a better outcome.

  4. User satisfaction of speech generating device (SGD) for daily communication [3 months vs. 4 months]

    Rating scale of user satisfaction with a range of 0-21 with a lower score representing a better outcome.

  5. User satisfaction of speech generating device (SGD) for daily communication [4 months vs. 5 months]

    Rating scale of user satisfaction with a range of 0-21 with a lower score representing a better outcome.

  6. User satisfaction of speech generating device (SGD) for daily communication [5 months vs. 6 months]

    Rating scale of user satisfaction with a range of 0-21 with a lower score representing a better outcome.

  7. User satisfaction of speech generating device (SGD) for daily communication [6 months vs. 7 months]

    Rating scale of user satisfaction with a range of 0-21 with a lower score representing a better outcome.

  8. User satisfaction of speech generating device (SGD) for daily communication [7 months vs. 8 months]

    Rating scale of user satisfaction with a range of 0-21 with a lower score representing a better outcome.

  9. User satisfaction of speech generating device (SGD) for daily communication [8 months vs. 9 months]

    Rating scale of user satisfaction with a range of 0-21 with a lower score representing a better outcome.

  10. User satisfaction of speech generating device (SGD) for daily communication [9 months vs. 10 months]

    Rating scale of user satisfaction with a range of 0-21 with a lower score representing a better outcome.

  11. User satisfaction of speech generating device (SGD) for daily communication [10 months vs. 11 months]

    Rating scale of user satisfaction with a range of 0-21 with a lower score representing a better outcome.

  12. User satisfaction of speech generating device (SGD) for daily communication [11 months vs. 12 months]

    Rating scale of user satisfaction with a range of 0-21 with a lower score representing a better outcome.

  13. User satisfaction of speech generating device (SGD) for daily communication [12 months vs. 13 months]

    Rating scale of user satisfaction with a range of 0-21 with a lower score representing a better outcome.

  14. User satisfaction of speech generating device (SGD) for daily communication [13 months vs. 14 months]

    Rating scale of user satisfaction with a range of 0-21 with a lower score representing a better outcome.

  15. User satisfaction of speech generating device (SGD) for daily communication [14 months vs. 15 months]

    Rating scale of user satisfaction with a range of 0-21 with a lower score representing a better outcome.

  16. User satisfaction of speech generating device (SGD) or daily communication [15 months vs. 16 months]

    Rating scale of user satisfaction with a range of 0-21 with a lower score representing a better outcome.

  17. User satisfaction of speech generating device (SGD) for daily communication [16 months vs. 17 months]

    Rating scale of user satisfaction with a range of 0-21 with a lower score representing a better outcome.

  18. User satisfaction of speech generating device (SGD) for daily communication [17 months vs. 18 months]

    Rating scale of user satisfaction with a range of 0-21 with a lower score representing a better outcome.

  19. User satisfaction of speech generating device (SGD) for daily communication [18 months vs. 19 months]

    Rating scale of user satisfaction with a range of 0-21 with a lower score representing a better outcome.

  20. User satisfaction of speech generating device (SGD) for daily communication [19 months vs. 20 months]

    Rating scale of user satisfaction with a range of 0-21 with a lower score representing a better outcome.

  21. User satisfaction of speech generating device (SGD) for daily communication [20 months vs. 21 months]

    Rating scale of user satisfaction with a range of 0-21 with a lower score representing a better outcome.

  22. User satisfaction of speech generating device (SGD) for daily communication [21 months vs. 22 months]

    Rating scale of user satisfaction with a range of 0-21 with a lower score representing a better outcome.

  23. User satisfaction of speech generating device (SGD) for daily communication [22 months vs. 23 months]

    Rating scale of user satisfaction with a range of 0-21 with a lower score representing a better outcome.

  24. User satisfaction of speech generating device (SGD) for daily communication [23 months vs. 24 months]

    Rating scale of user satisfaction with a range of 0-21 with a lower score representing a better outcome.

Eligibility Criteria

Criteria

Ages Eligible for Study:
14 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • natural speech does not meet daily communication needs requiring using a speech generating device

  • Has a diagnosis resulting in minimal movement interfering with direct selection to a keyboard or AAC display

  • age 14 and above

  • able to read a standard computer screen

  • able to follow instructions

  • English as their native language

Exclusion Criteria:
  • history of photosensitive epilepsy

  • open sores on the scalp

  • history of uncorrectable hearing loss

  • unavailable to participate during the times scheduled for the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 AAC Institute Clinic (ICAN Talk Clinic) Carnegie Pennsylvania United States 15102
2 University of Pittsburgh, AAC Performance and Testing Laboratory Pittsburgh Pennsylvania United States 15260

Sponsors and Collaborators

  • University of Pittsburgh
  • National Institute on Disability, Independent Living, and Rehabilitation Research

Investigators

  • Principal Investigator: Katya Hill, PhD, University of Pittsburgh

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Katya Hill, Associate Professor, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT04026581
Other Study ID Numbers:
  • STUDY19010094
  • 90IFDV0002-01-00
First Posted:
Jul 19, 2019
Last Update Posted:
Oct 6, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 6, 2021